These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24631189)

  • 1. Structure-based design and synthesis of tricyclic IAP (Inhibitors of Apoptosis Proteins) inhibitors.
    Hird AW; Aquila BM; Block MH; Hennessy EJ; Kamhi VM; Omer CA; Laing NM; Saeh JC; Sha L; Yang B
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1820-4. PubMed ID: 24631189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and biological activities of novel hexahydropyrazino[1,2-a]indole derivatives as potent inhibitors of apoptosis (IAP) proteins antagonists with improved membrane permeability across MDR1 expressing cells.
    Shiokawa Z; Hashimoto K; Saito B; Oguro Y; Sumi H; Yabuki M; Yoshimatsu M; Kosugi Y; Debori Y; Morishita N; Dougan DR; Snell GP; Yoshida S; Ishikawa T
    Bioorg Med Chem; 2013 Dec; 21(24):7938-54. PubMed ID: 24169315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.
    Zobel K; Wang L; Varfolomeev E; Franklin MC; Elliott LO; Wallweber HJ; Okawa DC; Flygare JA; Vucic D; Fairbrother WJ; Deshayes K
    ACS Chem Biol; 2006 Sep; 1(8):525-33. PubMed ID: 17168540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent and selective small-molecule inhibitors of cIAP1/2 proteins reveal that the binding of Smac mimetics to XIAP BIR3 is not required for their effective induction of cell death in tumor cells.
    Sun H; Lu J; Liu L; Yang CY; Wang S
    ACS Chem Biol; 2014 Apr; 9(4):994-1002. PubMed ID: 24521431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.
    Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M
    J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of aminopiperidine-based Smac mimetics as IAP antagonists.
    Hennessy EJ; Saeh JC; Sha L; MacIntyre T; Wang H; Larsen NA; Aquila BM; Ferguson AD; Laing NM; Omer CA
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1690-4. PubMed ID: 22264476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a novel class of dimeric Smac mimetics as potent IAP antagonists resulting in a clinical candidate for the treatment of cancer (AZD5582).
    Hennessy EJ; Adam A; Aquila BM; Castriotta LM; Cook D; Hattersley M; Hird AW; Huntington C; Kamhi VM; Laing NM; Li D; MacIntyre T; Omer CA; Oza V; Patterson T; Repik G; Rooney MT; Saeh JC; Sha L; Vasbinder MM; Wang H; Whitston D
    J Med Chem; 2013 Dec; 56(24):9897-919. PubMed ID: 24320998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth.
    Ward GA; Lewis EJ; Ahn JS; Johnson CN; Lyons JF; Martins V; Munck JM; Rich SJ; Smyth T; Thompson NT; Williams PA; Wilsher NE; Wallis NG; Chessari G
    Mol Cancer Ther; 2018 Jul; 17(7):1381-1391. PubMed ID: 29695633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theoretical studies on the interactions of XIAP-BIR3 domain with bicyclic and tricyclic core monovalent Smac mimetics.
    Ling B; Dong L; Zhang R; Wang Z; Liu Y; Liu C
    J Mol Graph Model; 2010 Nov; 29(3):354-62. PubMed ID: 20980180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
    Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
    Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dimeric Smac mimetics/IAP inhibitors as in vivo-active pro-apoptotic agents. Part II: Structural and biological characterization.
    Lecis D; Mastrangelo E; Belvisi L; Bolognesi M; Civera M; Cossu F; De Cesare M; Delia D; Drago C; Manenti G; Manzoni L; Milani M; Moroni E; Perego P; Potenza D; Rizzo V; Scavullo C; Scolastico C; Servida F; Vasile F; Seneci P
    Bioorg Med Chem; 2012 Nov; 20(22):6709-23. PubMed ID: 23062821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design, synthesis, and evaluation of the biological activity of novel phosphoroorganic small molecule IAP antagonists.
    Łupicka-Słowik A; Psurski M; Grzywa R; Cuprych M; Ciekot J; Goldeman W; Wojaczyńska E; Wojaczyński J; Oleksyszyn J; Sieńczyk M
    Invest New Drugs; 2020 Oct; 38(5):1350-1364. PubMed ID: 32270379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design, synthesis and characterization of potent, drug-like monomeric Smac mimetics as pro-apoptotic anticancer agents.
    Bianchi A; Ugazzi M; Ferrante L; Lecis D; Scavullo C; Mastrangelo E; Seneci P
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2204-8. PubMed ID: 22342627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
    Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
    J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting the inhibitor of Apoptosis Protein BIR3 binding domains.
    Jaquith JB
    Pharm Pat Anal; 2014 May; 3(3):297-312. PubMed ID: 24998289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and evaluation of tricyclic, conformationally constrained small-molecule mimetics of second mitochondria-derived activator of caspases.
    Zhang B; Nikolovska-Coleska Z; Zhang Y; Bai L; Qiu S; Yang CY; Sun H; Wang S; Wu Y
    J Med Chem; 2008 Dec; 51(23):7352-5. PubMed ID: 19012392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of small molecule inhibitors of signal transducer and activator of transcription 3 (STAT3) signaling pathway by virtual screening.
    Zhang M; Zhu W; Ding N; Zhang W; Li Y
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2225-9. PubMed ID: 23434226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF023 binding to XIAP-BIR1: searching drugs for regulation of the NF-κB pathway.
    Cossu F; Milani M; Grassi S; Malvezzi F; Corti A; Bolognesi M; Mastrangelo E
    Proteins; 2015 Apr; 83(4):612-20. PubMed ID: 25619915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of new bivalent quinazoline analogues as IAP antagonists.
    Bae I; Kim D; Choi J; Kim J; Kim M; Park B; Kim YH; Ahn YG; Hyung Kim H; Kim DK
    Bioorg Med Chem Lett; 2021 Feb; 34():127676. PubMed ID: 33166687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bivalent Smac mimetics with a diazabicyclic core as highly potent antagonists of XIAP and cIAP1/2 and novel anticancer agents.
    Peng Y; Sun H; Lu J; Liu L; Cai Q; Shen R; Yang CY; Yi H; Wang S
    J Med Chem; 2012 Jan; 55(1):106-14. PubMed ID: 22148838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.